List of bibliographic references
Number of relevant bibliographic references: 678.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000004 (2005) |
Masahiko Mihara [Japon] ; Norihiro Nishimoto ; Yoshiyuki Ohsugi | The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody. |
| 000008 (2005) |
Masahiko Mihara [Japon] ; Keiko Kasutani ; Makoto Okazaki ; Akito Nakamura ; Shigeto Kawai ; Masamichi Sugimoto ; Yoshihiro Matsumoto ; Yoshiyuki Ohsugi | Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. |
| 000009 (2005) |
Norihiro Nishimoto [Japon] | Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan. |
| 000010 (2005) |
Shumpei Yokota [Japon] ; Takako Miyamae ; Tomoyuki Imagawa ; Shigeki Katakura ; Rumiko Kurosawa ; Masaaki Mori | Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis. |
| 000013 (2005) |
Patricia Woo [Royaume-Uni] ; Nicholas Wilkinson [Royaume-Uni] ; Anne-Marie Prieur [France] ; Taunton Southwood [Royaume-Uni] ; Valentina Leone [Royaume-Uni] ; Polly Livermore [Royaume-Uni] ; Helena Wythe [Royaume-Uni] ; David Thomson [Royaume-Uni] ; Tadamitsu Kishimoto [Japon] | Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement |
| 000016 (2005) |
Yoshiyuki Ohsugi [Japon] ; Nobuyuki Tsuchimoto | [Pharmacological and clinical profile of anti-human IL-6 receptor antibody (tocilizumab, ACTEMRA), a novel therapeutic drug for Castleman's disease]. |
| 000018 (2006) |
Norihiro Nishimoto [Japon] | Interleukin-6 in rheumatoid arthritis. |
| 000022 (2006) |
Yasuaki Okuda [Japon] ; Kiyoshi Takasugi | Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. |
| 000030 (2006) |
Norihiro Nishimoto [Japon] ; Tadamitsu Kishimoto | Interleukin 6: from bench to bedside. |
| 000032 (2006) |
Hideko Nakahara [Japon] ; Norihiro Nishimoto | Anti-interleukin-6 receptor antibody therapy in rheumatic diseases. |
| 000034 (2007) |
Naoko Yoshio-Hoshino [Japon] ; Yasuo Adachi ; Chieko Aoki ; Alexander Pereboev ; David T. Curiel ; Norihiro Nishimoto | Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor. |
| 000041 (2007) |
Junya Kanda [Japon] ; Hiroshi Kawabata ; Yuhei Yamaji ; Tatsuo Ichinohe ; Takayuki Ishikawa ; Toshihiro Tamura ; Yutaka Furukawa ; Takeshi Kimura ; Toru Kita ; Takashi Uchiyama | Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody. |
| 000042 (2007) |
Norihiro Nishimoto [Japon] ; Jun Hashimoto ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Norikazu Murata ; Désirée Van Der Heijde ; Tadamitsu Kishimoto | Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. |
| 000053 (2008) |
Morihiko Ishizaki [Japon] ; Tetsuro Sasada ; Akane Kunitomi ; Yoshiteru Konaka ; Masato Yagita ; Shutaro Gunji ; Michiyuki Kanai ; Norihiro Nishimoto ; Arimichi Takabayashi | Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy. |
| 000060 (2007) |
Yoshiyuki Ohsugi [Japon] | Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases. |
| 000063 (2008) |
N. Nishimoto [Japon] ; T. Kishimoto | Humanized antihuman IL-6 receptor antibody, tocilizumab. |
| 000066 (2008) |
Atsushi Taga [Japon] ; Soichiro Kita ; Kaori Nishiura ; Tomonori Hayashi ; Mitsuhiro Kinoshita ; Atsushi Sato ; Kentaro Suzuki ; Shuji Kodama ; Kazuaki Kakehi | Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary. |
| 000070 (2008) |
Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. |
| 000072 (2008) |
Norihiro Nishimoto [Japon] ; Hideko Nakahara ; Naoko Yoshio-Hoshino ; Toru Mima | Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. |
| 000074 (2008) |
Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto | The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis. |
| 000077 (2008) |
Yasuo Adachi [Japon] ; Naoko Yoshio-Hoshino ; Norihiro Nishimoto | The blockade of IL-6 signaling in rational drug design. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/AffPays.i -k "Japon"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/AffPays.i \
-Sk "Japon" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Ncbi
|étape= Checkpoint
|type= indexItem
|index= AffPays.i
|clé= Japon
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
